These findings robustly suggested critical protective roles for Nrg4 in NASH progression that are primarily concerned with hepatocyte death and thus ameliorating inflammation and fibrosis, independent of lipid metabolism. This evidence concerns the gene NRG4 and metabolic dysfunction-associated steatohepatitis.